Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Earnings Winners & Losers: QGEN, WMGI, ALR, SN, and LIVN

Executive Summary

Diagnostics, orthopedics, and cardiovascular device companies are among those that wait until November to report their results for the quarter that ended at the end of September. Medtech Insight’s Earnings Winners & Losers highlights some of the companies that had news to celebrate, and a few that were disappointed with the quarter.


Related Content

Earnings Winners & Losers: BSX, BCR, EW, PHG, SYK, TFX, TMO
January Court Date Set for Abbott, Alere Merger
Liquid Biopsy In Oncology: An Increasingly Crowded Landscape
Deals Shaping the Medical Industry, August 2016
Alere Hit With Another Federal Subpoena, Casting More Doubt On Abbott Deal
Medtronic Acquires Smith And Nephew's Gynecology Business For $350m
More IVD Mergers: Qiagen Offers To Buy Exiqon; DiaSorin Buys Focus From Quest; Thermo Finishes Affymetrix Deal
US Ortho Extremities/Soft-Tissue Repair Market To Grow $2.2 Billion By 2019
Alere continues rebuild with sale of BBI and acquisition of US Diagnostics
LivaNova Set To Launch In Q3 With Sorin-Cyberonics Combination


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts